Arrowhead Pharmaceuticals (ARWR)
7.05
-0.17 -2.35%
NASDAQ
Sep 26, 16:59
Delayed 2m
USD
View All Key Stats
ARWR Key Stats
| Income Statement | |
| Revenue (TTM) | 0.1708M |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | -1.40 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | -84.24M |
| Profitability | |
| Gross Profit Margin (Quarterly) | -- |
| Profit Margin (Quarterly) | -49.06K% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield (TTM) | 0 |
| Price and Valuation | |
| Market Cap | 428.29M |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio (TTM) | 2464.08 |
| PE Ratio (TTM) | -- |
| Price to Book Value | 7.141 |
| Other | |
| Beta | Upgrade |
| Debt to Equity Ratio (Quarterly) | 0.0455 |
| Free Cash Flow (Quarterly) | -19.00M |
| Return on Equity (TTM) | -89.84% |
View All ARWR News
ARWR News
-
WireHeadlineTime (ET)
-
Yahoo09/10 17:55
-
MT Newswires09/07 08:36
-
noodls09/07 07:39
-
MT Newswires09/06 10:14
-
MT Newswires09/06 07:58
-
Yahoo09/06 07:31
-
Business Wire09/06 07:30
-
SA Breaking News09/02 17:35
-
Business Wire09/01 07:30
-
SA Breaking News08/30 08:18
View All Events
ARWR Events
| Date | Type | Description |
|---|---|---|
| 08/09/2016 16:30 EDT | Misc | Arrowhead Pharmaceuticals Inc Third Quarter Earnings Conference Call in 2016 |
| 08/09/2016 | Earnings | Arrowhead Pharmaceuticals Inc Third Quarter Earnings in 2016 Release |
| 05/10/2016 16:30 EDT | Misc | Arrowhead Pharmaceuticals Inc Second Quarter Earnings Conference Call in 2016 |
| 05/10/2016 | Earnings | Arrowhead Pharmaceuticals Inc Second Quarter Earnings in 2016 Release |
| 02/09/2016 16:30 EST | Misc | Arrowhead Research Corp First Quarter Earnings Results in 2016 |
| 02/09/2016 | Earnings | Arrowhead Research Corp First Quarter Earnings Results in 2016 Release |
ARWR Fundamentals
Income Statement View Statement
ARWR Ratings
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
Advertisement
One Page Reports
- One Page Report Download
Edit
Profile
- URL: http://www.arrowheadpharma.com
- Investor Relations URL: http://ir.arrowheadpharma.com/
- HQ State/Province: California
- Sector: Healthcare
- Industry: Biotechnology
- Next Earnings Release: N/A
- Last Earnings Release: August 09, 2016
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: N/A
- Description: Arrowhead Pharmaceuticals Inc is engaged in developing novel drugs to treat intractable diseases by silencing the genes. The Company's drug candidate ARC-520 is designed to treat chronic hepatitis B infection.
ARWR Comparables
EditARWR Excel Add-In Codes
- Name: =YCI("ARWR","name")
- Description: =YCI("ARWR","description")
- Sector: =YCI("ARWR","sector")
- Industry: =YCI("ARWR","industry")
- Est. Current Fiscal Year End: =YCI("ARWR","fye")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
Other ARWR Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- ARWR Tweets Stocktwits
Advertisement